Image

Global DNA Sequencing and Next-Generation Sequencing Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Medical Devices
  • Upcoming Report
  • Jun 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global DNA Sequencing and Next-Generation Sequencing Market, By Product Type (Instruments, Consumables, Services), Application (Research, Diagnostic, Drug Discovery, Clinical, Agriculture and Animal Research), Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), Technology (Sequencing By Synthesis, Nanopore Sequencing, Sequencing By Ligation (SBL), Ion Semiconductor Sequencing, Pyrosequencing, Chain Termination Sequencing, Single-Molecule Real-Time Sequencing (SMRT), and Others), Platform (Sanger, Next Generation Sequencing, qPCR and Others), End-user (Academic Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies)– Industry Trends and Forecast to 2029

DNA Sequencing and Next-Generation Sequencing Market

Market Analysis and Size

The DNA sequencing and next-generation sequencing market will benefit from improved reimbursement and regulatory scenarios for next-generation sequencing-based diagnostic testing. The favorable financing conditions across the world for genomics research will give attractive expansion prospects. The market expansion is accelerated by the development of cost-effective next-generation sequencing services and products for researchers.

Data Bridge Market Research analyses that the DNA sequencing and next-generation sequencing market which was USD 13.82 billion in 2021, would rocket up to USD 50.04 billion by 2029, and is expected to undergo a CAGR of 17.45% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Instruments, Consumables, Services), Application (Research, Diagnostic, Drug Discovery, Clinical, Agriculture and Animal Research), Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), Technology (Sequencing By Synthesis, Nanopore Sequencing, Sequencing By Ligation (SBL), Ion Semiconductor Sequencing, Pyrosequencing, Chain Termination Sequencing, Single-Molecule Real-Time Sequencing (SMRT), and Others), Platform (Sanger, Next Generation Sequencing, qPCR and Others), End-user (Academic Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Illumina Inc. (U.S), Thermo Fischer Scientific Inc. (U.S), Oxford Nanopore Technologies plc (U.K), Agilent Technologies, Inc. (U.S), BGI (China), PerkinElmer Inc. (U.S), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (U.S), Hamilton Company (U.S), Macrogen Inc. (South Korea), Zymo Research Corporation (U.S), Tecan Trading AG (Switzerland) 

Market Opportunities

  • Increasing research and development activities in North America and Europe
  • Growing use of NGS technology by pharmaceutical and biopharmaceutical companies

Market Definition

High-throughput sequencing is another name for next-generation sequencing. NGS allows for fast base pair sequencing of DNA samples. NGS is advancing drug development and paving the way for future personalized medicine, genetic illnesses, and clinical diagnostics. Furthermore, next-generation sequencing (NGS) is a massively parallel sequencing method capable of determining the order of nucleotides in a full genome with scalability, ultra-high throughput, and rapid speed.

DNA Sequencing and Next-Generation Sequencing Market Dynamics

Drivers

  • Increasing number of cancer cases

The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall growth of the DNA next generation sequencing industry.

  • Rising R&D activities for developing novel next generation sequencing technologies

Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of genetic disorders among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

  • Increasing advantages of next generation sequencing techniques

In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue.

Opportunities

The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the DNA next generation sequencing industry.

Restraints/Challenges

However, lack of skilled professionals, and ethical and legal limitation associated with NGS are expected to restrict the market growth during the forecast period.

This DNA sequencing and next-generation sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the DNA sequencing and next-generation sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 impact on DNA Sequencing and Next-Generation Sequencing Market

The COVID-19 epidemic had a huge influence on the world as a whole, causing economic collapse and death. It has resulted in a worldwide pandemic that is extremely transmissible. With the advancement of technology, next-generation sequencing is becoming increasingly important in a variety of fields. From manufacturing PPE kits to inventing test kits to detect the virus and vaccines to prevent transmission, a number of pharmaceutical businesses and agencies have contributed to reducing the infection's impact. To combat the virus, businesses have strengthened their R&D and production workforce. Because of the increasing benefit of determining and finding the genetic sequence of a virus, which helps scientists to comprehend the virus's entire mutation, the overall influence on the next generation sequencing industry and market is expected to be beneficial. Hundreds of coronaviruses and SARS-CoV-2 genomes which were determined with NGS are publicly available for researchers to study the origin of COVID-19.

Recent Development

  • In December 2020, Eurofins Genomics has released SARS-CoV-2 NGS services that are both cost-effective and optimised, allowing for entire viral genome sequencing.
  • In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.

The DNA sequencing and next-generation sequencing market is segmented on the basis of product, type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Instruments
  • Consumables
  • Services

Type

Application

  • Research application
  • Clinical application
  • Others

Technology

  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Others

End-user

  • Academic institutes and research centers
  • Hospitals and clinics
  • Pharmaceutical and biotechnology companies
  • Others

DNA Sequencing and Next-Generation Sequencing Market Regional Analysis/Insights

The DNA sequencing and next-generation sequencing market is analysed and market size insights and trends are provided by country, product, type, technology, application and end-user as referenced above.

The countries covered in the DNA sequencing and next-generation sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the presence of several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.

Asia-Pacific is expected to be the fastest-growing regional market from 2022 to 2029. The presence of local companies, such as BGI Genomics, and NGS service providers including First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd., and others is expected to drive the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and DNA Sequencing and Next-Generation Sequencing Market Share Analysis

The DNA sequencing and next-generation sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to DNA sequencing and next-generation sequencing market.

Some of the major players operating in the DNA sequencing and next-generation sequencing market are:

  • Illumina Inc. (U.S)
  • Thermo Fischer Scientific Inc. (U.S)
  • Oxford Nanopore Technologies plc (U.K)
  • Agilent Technologies, Inc. (U.S)
  • BGI (China)
  • PerkinElmer Inc. (U.S)
  • QIAGEN (Germany)
  • Eurofins Scientific (Luxembourg)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Takara Bio Inc. (Japan)
  • GENEWIZ, Inc. (U.S)
  • Hamilton Company (U.S)
  • Macrogen Inc. (South Korea)
  • Zymo Research Corporation(U.S)
  • Tecan Trading AG (Switzerland) 


SKU-
Why Choose Us


Frequently Asked Questions

Factors such as growing R&D activities for producing therapies utilized in treatment of genetic disorders will escalate the need for next generation sequencing method over the analysis period. Increasing investments in R&D activities are the major growth driving factors.
The DNA Sequencing and Next-Generation Sequencing Market is to grow at a CAGR of 17.45% during the forecast by 2029.
The major players operating in the DNA Sequencing and Next-Generation Sequencing Market are Illumina Inc. (U.S), Thermo Fischer Scientific Inc. (U.S), Oxford Nanopore Technologies plc (U.K), Agilent Technologies, Inc. (U.S), BGI (China), PerkinElmer Inc. (U.S), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (U.S), Hamilton Company (U.S), Macrogen Inc. (South Korea), Zymo Research Corporation (U.S), Tecan Trading AG (Switzerland) .
The DNA Sequencing and Next-Generation Sequencing Market value is expected USD 50.04 billion by 2029.